3.55
0.02 (0.57%)
0.02 (0.57%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.15 | -4.08% | 3.53 | 3.47 | 3.82 | 3.69 | 3.68 | 18:44:32 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.40 | 3.60 | 0.20 | 5.56% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,325 | 395,832 | $ 3.65 | $ 1,445,410 | 361,810 | 1.60 - 5.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:28:47 | 1 | $ 3.55 | USD |
Aptinyx Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 161.16M | 45.66M | 44.12M | $ 3.67M | $ - | -1.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 10.00 | 3.40% |
Aptinyx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.00 | 4.00 | 3.40 | 3.66 | 277,944 | -0.47 | -11.75% |
| 1 Month | 4.04 | 4.56 | 3.16 | 3.88 | 363,005 | -0.51 | -12.62% |
| 3 Months | 2.20 | 4.56 | 1.60 | 3.21 | 259,724 | 1.33 | 60.45% |
| 6 Months | 3.96 | 5.30 | 1.60 | 3.57 | 283,542 | -0.43 | -10.86% |
| 1 Year | 3.40 | 5.30 | 1.60 | 3.52 | 214,418 | 0.13 | 3.82% |
| 3 Years | 17.40 | 32.25 | 1.60 | 7.39 | 230,252 | -13.87 | -79.71% |
| 5 Years | 17.40 | 32.25 | 1.60 | 7.39 | 230,252 | -13.87 | -79.71% |
Aptinyx Description
| Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder. |
